T cells targeting NY-ESO-1 demonstrate efficacy against disseminated neuroblastoma.
Singh N, Kulikovskaya I, Barrett DM, Binder-Scholl G, Jakobsen B, Martinez D, Pawel B, June CH, Kalos MD, Grupp SA.
Singh N, et al.
Oncoimmunology. 2015 Aug 12;5(1):e1040216. doi: 10.1080/2162402X.2015.1040216. eCollection 2016.
Oncoimmunology. 2015.
PMID: 26942053
Free PMC article.